PHK
OVID icon

Point72 Hong Kong’s Ovid Therapeutics OVID Stock Holding History

Point72 Hong Kong’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,771
Closed -$27K – 1968
2020
Q3 		$27K Buy
4,771
+4,447
+1,373% +$29.8K ﹤0.01% 813
2020
Q2 		$2K Buy
+324
New +$1.51K ﹤0.01% 1076
2020
Q1 		– Sell
-86
Closed – – 1245
2019
Q4 		$0 Buy
+86
New +$272 ﹤0.01% 1383
2019
Q2 		– Sell
-374
Closed -$1K – 1337
2019
Q1 		$1K Buy
+374
New +$935 ﹤0.01% 952

Other funds holding OVID

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Hong Kong's OVID Position: Q4 2020 in Review

Point72 Hong Kong sold out of Ovid Therapeutics (OVID) in Q4 2020, closing a stake of 4,771 shares — an estimated $27K sold.

Point72 Hong Kong first reported a position in OVID in Q1 2019 and held it in 4 quarters. The position peaked at $27K in Q3 2020. 83 funds tracked by Wall St. Rank hold OVID as of Q4 2020.

  • Point72 Hong Kong reported no remaining Ovid Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 4,771 Ovid Therapeutics shares in Q4 2020, an estimated $27K.
  • Point72 Hong Kong first reported a position in Ovid Therapeutics in Q1 2019 and held it in 4 quarters.
  • Point72 Hong Kong's Ovid Therapeutics position peaked at $27K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2020.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.